Man Group PLC Immuno Gen, Inc. Transaction History

Man Group PLC

  • $37.6 Billion
  • Q2 2024

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
SELL
$12.46 - $29.95 $1.6 Million - $3.85 Million
-128,647 Reduced 19.38%
535,000 $15.9 Million
Q3 2023

Nov 14, 2023
SELL
$14.09 - $19.87 $261,792 - $369,184
-18,580 Reduced 2.72%
663,647 $10.5 Million
Q2 2023

Aug 14, 2023
BUY
$3.75 - $20.05 $1.99 Million - $10.6 Million
529,998 Added 348.16%
682,227 $12.9 Million
Q1 2023

May 15, 2023
SELL
$3.67 - $4.92 $233,166 - $312,582
-63,533 Reduced 29.45%
152,229 $584,000
Q4 2022

Feb 14, 2023
BUY
$4.55 - $6.31 $981,717 - $1.36 Million
215,762 New
215,762 $1.07 Million
Q1 2021

May 17, 2021
SELL
$6.5 - $10.53 $973,667 - $1.58 Million
-149,795 Closed
0 $0
Q4 2020

Feb 16, 2021
SELL
$3.7 - $7.66 $61,790 - $127,922
-16,700 Reduced 10.03%
149,795 $966,000
Q3 2020

Nov 16, 2020
SELL
$3.45 - $4.89 $8,280 - $11,736
-2,400 Reduced 1.42%
166,495 $599,000
Q2 2020

Aug 14, 2020
SELL
$3.32 - $5.34 $156,372 - $251,514
-47,100 Reduced 21.81%
168,895 $777,000
Q1 2020

May 15, 2020
SELL
$2.12 - $6.8 $24,380 - $78,200
-11,500 Reduced 5.06%
215,995 $737,000
Q4 2019

Feb 18, 2020
SELL
$2.25 - $5.8 $13,275 - $34,220
-5,900 Reduced 2.53%
227,495 $1.16 Million
Q3 2019

Nov 14, 2019
SELL
$2.22 - $3.39 $469,885 - $717,527
-211,660 Reduced 47.56%
233,395 $565,000
Q2 2019

Aug 14, 2019
SELL
$1.8 - $3.3 $3,420 - $6,270
-1,900 Reduced 0.43%
445,055 $966,000
Q1 2019

May 15, 2019
SELL
$2.41 - $5.91 $8,676 - $21,276
-3,600 Reduced 0.8%
446,955 $1.21 Million
Q4 2018

Feb 14, 2019
BUY
$3.94 - $9.7 $359,938 - $886,143
91,355 Added 25.43%
450,555 $2.16 Million
Q3 2018

Nov 14, 2018
BUY
$8.6 - $11.26 $2.89 Million - $3.79 Million
336,392 Added 1474.89%
359,200 $3.4 Million
Q2 2018

Aug 14, 2018
BUY
$9.52 - $12.15 $217,132 - $277,117
22,808 New
22,808 $222,000

Others Institutions Holding IMGN

# of Institutions
10
Shares Held
1.41M
Call Options Held
0
Put Options Held
0
View Full List

About ImmunoGen, Inc.

IMGN Quotes by TradingView
  • Ticker IMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 220,712,992
  • Description
  • ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...
More about IMGN
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email